Corify Care has developed ACORYS®, a non-invasive cardiac mapping system that enables clinicians to perform real-time, beat-to-beat global cardiac mapping in under 10 minutes. This technology addresses the limitations of traditional catheter-based mapping by providing a comprehensive view of the entire heart, enhancing diagnostic accuracy and patient safety.

This biotechnology company specializes in the early diagnosis of ocular pathologies through the use of specific biomarkers, focusing on corneal diseases. By developing targeted treatments, the company aims to enhance corneal integrity and improve patients' quality of life.

Alya Red is a virtual human that employs machine learning algorithms to analyze individual health data and create personalized medical treatment plans. This technology aims to enhance treatment efficacy and improve patient outcomes, ultimately increasing patients' longevity.

This startup provides hospital data management software that automates the capture and recording of patient journey data within operating rooms. Its dashboard visualizes information on patient flow, supply consumption (equipment, medical devices, medication), and asset utilization, enabling hospitals to efficiently manage resources and track activity.

The startup develops diagnostic devices that utilize a patented intravaginal probe to transmit torsional waves for assessing changes in tissue consistency. This technology enables medical practitioners to accurately identify false indications of premature birth, thereby improving women's health outcomes.

Leuko Labs is developing PointCheck™, a non-invasive device that uses light to monitor white blood cell levels by imaging blood cells in superficial capillaries. This technology enables frequent testing for millions of immunosuppressed patients, reducing the risk of infection without the need for blood draws.

Magentiq Eye LTD develops the MAGENTIQ-COLO System, an AI-powered platform for automatic polyp detection and analysis during colonoscopy procedures. This technology enhances adenoma detection rates, significantly reducing the risk of colorectal cancer by improving diagnostic accuracy and clinical decision-making in gastroenterology.

MiMARK is developing WomEC, an in vitro diagnostic immunoassay that utilizes a panel of five protein biomarkers in uterine fluids to accurately detect endometrial cancer, achieving 99% sensitivity and 79% specificity. This approach addresses the limitations of traditional endometrial biopsies, which fail to diagnose 31% of patients and often require invasive procedures like hysteroscopy.

Omniscope provides immune system analysis platforms tailored for pharmaceutical development, sports performance optimization, and longevity research. The company utilizes advanced tracking and profiling methods to generate actionable insights from immune cell activity data. This intelligence supports the engineering of novel therapies and the enhancement of healthspan across various applications.

Sycai Medical develops an AI-powered radiology assistant that automates the detection and monitoring of pre-cancerous lesions in abdominal CT scans, integrating seamlessly into existing hospital PACS systems. This technology enables radiologists to identify incidental findings and track lesion evolution without manual input, enhancing early cancer detection and improving patient outcomes.